Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Nicolau

Showing results (1-10 of 632) with videos related to

Pageof 64
Sort By:
The Annals of Pharmacotherapy|July 1, 2004
Optimizing Efficacy in CARTIs: introductionDavid P Nicolau
Pharmacotherapy|January 17, 2002
Maximizing outcomes in respiratory tract infections in the age of resistanceDavid P Nicolau
Expert Opinion on Pharmacotherapy|March 5, 2004
Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycinDavid P Nicolau
The American Journal of Managed Care|December 18, 2004
Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infectionsDavid P Nicolau
Expert Opinion on Pharmacotherapy|December 14, 2007
Carbapenems: a potent class of antibioticsDavid P Nicolau
Current Opinion in Infectious Diseases|January 5, 2011
Current challenges in the management of the infected patientDavid P Nicolau
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 24, 2003
Optimizing outcomes with antimicrobial therapy through pharmacodynamic profilingDavid P Nicolau
Critical Care (London, England)|June 17, 2008
Pharmacodynamic optimization of beta-lactams in the patient care settingDavid P Nicolau
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 9, 2008
Bugs versus drugs: what is the pharmacist's challenge?David P Nicolau
Expert Opinion on Investigational Drugs|July 7, 2015
Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infectionsDavid P Nicolau
Pageof 64

Showing results (1-10 of 632) with videos related to

Sort By:
Pageof 64
The Annals of Pharmacotherapy|July 1, 2004
Optimizing Efficacy in CARTIs: introductionDavid P Nicolau
Pharmacotherapy|January 17, 2002
Maximizing outcomes in respiratory tract infections in the age of resistanceDavid P Nicolau
Expert Opinion on Pharmacotherapy|March 5, 2004
Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycinDavid P Nicolau
The American Journal of Managed Care|December 18, 2004
Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infectionsDavid P Nicolau
Expert Opinion on Pharmacotherapy|December 14, 2007
Carbapenems: a potent class of antibioticsDavid P Nicolau
Current Opinion in Infectious Diseases|January 5, 2011
Current challenges in the management of the infected patientDavid P Nicolau
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 24, 2003
Optimizing outcomes with antimicrobial therapy through pharmacodynamic profilingDavid P Nicolau
Critical Care (London, England)|June 17, 2008
Pharmacodynamic optimization of beta-lactams in the patient care settingDavid P Nicolau
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 9, 2008
Bugs versus drugs: what is the pharmacist's challenge?David P Nicolau
Expert Opinion on Investigational Drugs|July 7, 2015
Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infectionsDavid P Nicolau
Pageof 64